Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer

NCT02643407 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

488

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Docetaxel
DRUG: Nedaplatin
DRUG: Cisplatin

Sponsor

Guangdong Association of Clinical Trials